King Levoxyl Patent Suit Against KV Dismissed
This article was originally published in The Pink Sheet Daily
Executive Summary
Delaware federal court dismisses King’s Levoxyl suit against KV Pharmaceutical with prejudice. Merck notifies KV that it will not file suit challenging KV’s Sinemet CR ANDA.